{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:06:02Z","timestamp":1793325962947,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.blre.2009.04.002","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T04:24:38Z","timestamp":1242188678000},"page":"167-176","source":"Crossref","is-referenced-by-count":150,"title":["Disseminated intravascular coagulation in obstetric disorders and its acute haematological management"],"prefix":"10.1016","volume":"23","author":[{"given":"Jecko","family":"Thachil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hock","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2009.04.002_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2141.2007.06977.x","article-title":"The Yin-Yang of thrombin and activated protein C","volume":"140","author":"Dutt","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.04.002_bib2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nri2402","article-title":"Harmful molecular mechanisms in sepsis","volume":"8","author":"Rittirsch","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.blre.2009.04.002_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/beog.2001.0204","article-title":"Disseminated intravascular coagulation","volume":"15","author":"Letsky","year":"2001","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"10.1016\/j.blre.2009.04.002_bib4","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/0002-9378(95)91474-9","article-title":"Amniotic fluid embolism: analysis of the national registry","volume":"172","author":"Clark","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF03019822","article-title":"Amniotic fluid embolus: a review of the literature","volume":"48","author":"Davies","year":"2001","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.blre.2009.04.002_bib6","first-page":"573","article-title":"Fetal death in utero","volume":"14","author":"Pritchard","year":"1959","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib7","first-page":"449","article-title":"Pathogenesis and treatment of coagulation defects resulting from fetal death","volume":"32","author":"Jimenez","year":"1968","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/j.1600-0412.1999.780306.x","article-title":"Multiple pregnancies with single intrauterine demise","volume":"78","author":"Petersen","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.blre.2009.04.002_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)71003-5","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2009.04.002_bib10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(02)07804-2","article-title":"Surgically obtained sperm and risk of gestational hypertension and pre-eclampsia","volume":"359","author":"Dekker","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2009.04.002_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1067\/mob.2002.119176","article-title":"Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation","volume":"186","author":"Ishihara","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9378(99)70239-5","article-title":"Preeclampsia: an excessive maternal inflammatory response to pregnancy","volume":"180","author":"Redman","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib13","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(03)13177-7","article-title":"Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia","volume":"361","author":"Savvidou","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2009.04.002_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJM199008163230710","article-title":"Platelets and the beginnings of preeclampsia","volume":"323","author":"Redman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2009.04.002_bib15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.AOG.0000239439.04364.9a","article-title":"Placental abruption","volume":"108","author":"Oyelese","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib16","first-page":"785","article-title":"A case of fatal hemorrhagic diathesis, with premature detachment of the placenta","volume":"44","author":"De Lee","year":"1901","journal-title":"Am J Obstet Dis Women Child"},{"key":"10.1016\/j.blre.2009.04.002_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0029-7844(96)00478-4","article-title":"Etiologic determinants of abruptio placentae","volume":"89","author":"Kramer","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clim.2003.09.004","article-title":"Anti-fetal immune response mechanisms may be involved in the pathogenesis of placental abruption","volume":"110","author":"Steinborn","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.blre.2009.04.002_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/01.AOG.0000207560.41604.19","article-title":"Placental abruption in term and preterm gestations: evidence for heterogeneity in clinical pathways","volume":"107","author":"Ananth","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/j.1600-0412.1999.780503.x","article-title":"Abruptio placentae and chorioamnionitis \u2013microbiological and histologic correlation","volume":"78","author":"Rana","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.blre.2009.04.002_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0095-5108(18)30794-2","article-title":"The obstetric patient and disseminated intravascular coagulation","volume":"13","author":"Weiner","year":"1986","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.blre.2009.04.002_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1182\/asheducation-2007.1.187","article-title":"Blood and coagulation support in trauma care","volume":"2007","author":"Hess","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2009.04.002_bib23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1189\/jlb.0607373","article-title":"Inflammation, endothelium, and coagulation in sepsis","volume":"83","author":"Schouten","year":"2008","journal-title":"J Leukocyte Biol"},{"key":"10.1016\/j.blre.2009.04.002_bib24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ajog.2005.08.044","article-title":"Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child","volume":"195","author":"Martin","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2141.2008.07324.x","article-title":"Advances in understanding of pathogenesis of aHUS and HELLP","volume":"143","author":"Fang","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.04.002_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0146-0005(98)80045-1","article-title":"Acute fatty liver of pregnancy","volume":"22","author":"Bacq","year":"1998","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.blre.2009.04.002_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9378(96)70396-4","article-title":"Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy","volume":"174","author":"Castro","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2006.11.004","article-title":"Coagulation 2006: a modern view of hemostasis","volume":"21","author":"Hoffman","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.blre.2009.04.002_bib29","doi-asserted-by":"crossref","unstructured":"Oliver J, Monroe D, Roberts H, et al. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 1999;19:170\u20137.","DOI":"10.1161\/01.ATV.19.1.170"},{"key":"10.1016\/j.blre.2009.04.002_bib30","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1016\/S0021-9258(18)34276-5","article-title":"Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation","volume":"257","author":"Esmon","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2009.04.002_bib31","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2004-05-1896","article-title":"Activated protein C induces the release of microparticle-associated endothelial protein C receptor","volume":"105","author":"P\u00e9rez-Casal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.04.002_bib32","doi-asserted-by":"crossref","first-page":"31869","DOI":"10.1016\/S0021-9258(18)31776-9","article-title":"The mechanism of inactivation of human factor V and human factor Va by activated protein C","volume":"269","author":"Kalafatis","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2009.04.002_bib33","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0037-1616518","article-title":"Structure and biology of tissue factor pathway inhibitor","volume":"86","author":"Bajaj","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-0037-1613368","article-title":"Molecular mechanisms of initiation of fibrinolysis by fibrin","volume":"89","author":"Medved","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib35","doi-asserted-by":"crossref","first-page":"16603","DOI":"10.1074\/jbc.271.28.16603","article-title":"TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin\u2013thrombomodulin complex","volume":"271","author":"Bajzar","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2009.04.002_bib36","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0021-9258(17)43427-2","article-title":"\u2018Clotspeed\u2019, a mathematical simulation of the functional properties of prothrombinase","volume":"259","author":"Nesheim","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2009.04.002_bib37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2141.1988.tb02405.x","article-title":"A combination of factor Xa and phosphatidylcholine\u2013phosphatidylserine vesicles bypasses factor VIII in vivo","volume":"69","author":"Giles","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.04.002_bib38","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1172\/JCI111648","article-title":"Studies of factors V and VIII:C in an animal model of disseminated intravascular coagulation","volume":"74","author":"Giles","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2009.04.002_bib39","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0021-9258(17)42183-1","article-title":"Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C","volume":"269","author":"Smirnov","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2009.04.002_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V65.2.319.319","article-title":"The role of activated human platelets in prothrombin and factor X activation","volume":"65","author":"Rosing","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.04.002_bib41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/01.ATV.18.3.458","article-title":"Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes","volume":"18","author":"Moyer","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2009.04.002_bib42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0037-1613378","article-title":"Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction","volume":"89","author":"Bretelle","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-2275(20)38390-5","article-title":"Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins","volume":"30","author":"Cabana","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1016\/j.blre.2009.04.002_bib44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1160\/TH03-08-0548","article-title":"Prothrombinase enhancement through quantitative and qualitative changes affecting very low density lipoprotein in complex with C-reactive protein","volume":"9","author":"Dennis","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1172\/JCI5006","article-title":"High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C","volume":"103","author":"Griffin","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2009.04.002_bib46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0029-7844(96)00514-5","article-title":"Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis","volume":"89","author":"Sattar","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0038-1653724","article-title":"Tissue factor activity of syncytiotrophoblast plasma membranes and tumoral trophoblast cells in culture","volume":"73","author":"Reverdiau","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib48","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1160\/TH04-01-0033","article-title":"Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis","volume":"92","author":"Aharon","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib49","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood-2004-09-3724","article-title":"A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice","volume":"105","author":"Pedersen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.04.002_bib50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2009.04.002_bib51","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1055\/s-0037-1615021","article-title":"Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension","volume":"79","author":"Boffa","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib52","doi-asserted-by":"crossref","unstructured":"Isermann B, Sood R, Pawlinski R, et al. The thrombomodulin\u2013protein C system is essential for the maintenance of pregnancy. Nat Med 2003;9:331\u20137.","DOI":"10.1038\/nm825"},{"key":"10.1016\/j.blre.2009.04.002_bib53","doi-asserted-by":"crossref","first-page":"43335","DOI":"10.1074\/jbc.M207538200","article-title":"Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality","volume":"277","author":"Gu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2009.04.002_bib54","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2004-03-0793","article-title":"Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for foetal death","volume":"104","author":"Hurtado","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.04.002_bib55","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1055\/s-0037-1615035","article-title":"Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy","volume":"79","author":"Clark","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib56","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood.V68.4.881.881","article-title":"Functional and immunologic protein S levels are decreased during pregnancy","volume":"68","author":"Comp","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.04.002_bib57","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2141.1995.tb05610.x","article-title":"Development of resistance to activated protein C during pregnancy","volume":"90","author":"Cumming","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.04.002_bib58","first-page":"132","article-title":"Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium","volume":"80","author":"Bremme","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-2115(97)02734-6","article-title":"Coagulation and fibrinolysis changes in normal pregnancy","volume":"73","author":"Cerneca","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.blre.2009.04.002_bib60","first-page":"45","article-title":"Blood coagulation and fibrinolysis during normal pregnancy","volume":"29","author":"van Wersch","year":"1991","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.blre.2009.04.002_bib61","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1538-7836.2008.03207.x","article-title":"Acute endothelial tissue plasminogen activator release in pregnancy","volume":"7","author":"Robb","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.blre.2009.04.002_bib62","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1097\/00001721-200306001-00016","article-title":"Characterization of thrombin activatable fibrinolysis inhibitor in normal and acquired haemostatic dysfunction","volume":"14","author":"Toh","year":"2003","journal-title":"Blood Coagul Fibrin"},{"key":"10.1016\/j.blre.2009.04.002_bib63","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1365-2141.2001.03082.x","article-title":"TAFI antigen and D-dimer levels during normal pregnancy and at delivery","volume":"115","author":"Chabloz","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.04.002_bib64","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1160\/TH04-06-0387","article-title":"Thrombin activatable fibrinolysis inhibitor and its fibrinolytic effect in normal pregnancy","volume":"92","author":"Mousa","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib65","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.placenta.2003.11.004","article-title":"Phosphatidylserine efflux and intercellular fusion in a BeWo model of human villous cytotrophoblast","volume":"25","author":"Das","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.blre.2009.04.002_bib66","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/0002-9378(95)90502-2","article-title":"Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts","volume":"172","author":"Katsuragawa","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1521-6934(03)00019-1","article-title":"Haemostasis in normal and abnormal pregnancy","volume":"17","author":"O\u2019Riordan","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.blre.2009.04.002_bib68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1471-0528.1978.tb15821.x","article-title":"Platelet lifespan in normal pregnancy as determined by a non-radioisotopic technique","volume":"85","author":"Wallenburg","year":"1978","journal-title":"BJOG"},{"key":"10.1016\/j.blre.2009.04.002_bib69","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1182\/blood.V56.1.88.88","article-title":"Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation","volume":"56","author":"Neame","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.blre.2009.04.002_bib70","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/s-0037-1615899","article-title":"Disseminated intravascular coagulation: state of the art","volume":"82","author":"Levi","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.thromres.2004.04.008","article-title":"Fibrinogen and high molecular weight fibrinogen during and after normal pregnancy","volume":"114","author":"Manten","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2009.04.002_bib72","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage","volume":"5","author":"Charbit","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib73","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1055\/s-0038-1656098","article-title":"A reference material for harmonisation of D-dimer assays","volume":"77","author":"Nieuwenhuizen","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib74","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1055\/s-0037-1616068","article-title":"Towards a definition, clinical and laboratory criteria and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib75","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1538-7836.2007.02313.x","article-title":"The scoring system of the SSC on DIC of the ISTH: a 5-year overview","volume":"5","author":"Toh","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0268-960X(90)90014-J","article-title":"Assessment of hypercoagulable states by measurement of activation fragments and peptides","volume":"4","author":"Boisclair","year":"1990","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2009.04.002_bib77","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1471-0528.1993.tb15264.x","article-title":"Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia","volume":"100","author":"Cadroy","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.blre.2009.04.002_bib78","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1471-0528.1994.tb13147.x","article-title":"Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia","volume":"101","author":"Halligan","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.blre.2009.04.002_bib79","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00006250-198812000-00006","article-title":"The mechanism of reduced antithrombin III activity in women with preeclampsia","volume":"72","author":"Weiner","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib80","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0037-1614413","article-title":"Thrombomodulin: a new marker for placental abruption","volume":"81","author":"Magriples","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib81","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2141.2001.02964.x","article-title":"Mutations in the thrombomodulin and endothelial protein C receptor genes in women with late fetal loss","volume":"114","author":"Franchi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.04.002_bib82","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/humrep\/del436","article-title":"Variations in the thrombomodulin and endothelial protein C receptor genes in couples with recurrent miscarriage","volume":"22","author":"Kaare","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.blre.2009.04.002_bib83","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1055\/s-0037-1614933","article-title":"Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia","volume":"79","author":"Estell\u00e9s","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib84","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1067\/mob.2002.122969","article-title":"A longitudinal study of biochemical variables in women at risk of preeclampsia","volume":"187","author":"Chappell","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib85","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-0037-1613269","article-title":"Does thrombin activatable fibrinolysis inhibitor contribute to impairment of fibrinolysis in patients with preeclampsia and\/or intrauterine fetal growth retardation?","volume":"88","author":"Antovic","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib86","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0049-3848(99)00092-4","article-title":"A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results","volume":"96","author":"He","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2009.04.002_bib87","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1067\/mob.2002.124279","article-title":"Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction?","volume":"187","author":"VanWijk","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl. A","key":"10.1016\/j.blre.2009.04.002_bib88","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.placenta.2007.11.016","article-title":"Circulating microparticles in normal pregnancy and pre-eclampsia","volume":"29","author":"Redman","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.blre.2009.04.002_bib89","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0002-9378(98)70389-8","article-title":"Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies","volume":"179","author":"Higgins","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.blre.2009.04.002_bib90","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0049-3848(00)00339-X","article-title":"Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity","volume":"100","author":"Josic","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2009.04.002_bib91","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.0007-1048.2001.03295.x","article-title":"Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients","volume":"116","author":"Preston","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2009.04.002_bib92","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2004.08.003","article-title":"Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency","volume":"32","author":"Kreuz","year":"2005","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.blre.2009.04.002_bib93","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1213\/ane.0b013e318163fb26","article-title":"Fibrinogen in craniosynostosis surgery","volume":"106","author":"Haas","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.blre.2009.04.002_bib94","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-3148.2008.00854.x","article-title":"Fibrinogen concentrate for acquired hypofibrinogenaemic states","volume":"18","author":"Weinkove","year":"2008","journal-title":"Transfus Med"},{"key":"10.1016\/j.blre.2009.04.002_bib95","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1056\/NEJM197010082831502","article-title":"Heparin therapy in septicemia with disseminated intravascular coagulation","volume":"283","author":"Corrigan","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2009.04.002_bib96","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2007-1002795","article-title":"Treatment of disseminated intravascular coagulation","volume":"14","author":"Feinstein","year":"1988","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2009.04.002_bib97","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/s-2004-815632","article-title":"BI51017 Study Group. Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study","volume":"29","author":"Kobayashi","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2009.04.002_bib98","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2009.04.002_bib99","doi-asserted-by":"crossref","unstructured":"Kobayashi T, Terao T, Maki M, et al. Activated protein C is effective for disseminated intravascular coagulation associated with placental abruption. Thromb Haemost 1999;82:1363.","DOI":"10.1055\/s-0037-1614394"},{"key":"10.1016\/j.blre.2009.04.002_bib100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/ACO.0b013e3282f8e257","article-title":"Strategies to manage major obstetric haemorrhage","volume":"21","author":"Wise","year":"2008","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.blre.2009.04.002_bib101","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.ogx.0000180909.31293.cf","article-title":"Postpartum hemorrhage and transfusion of blood and blood components","volume":"60","author":"Jansen","year":"2005","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.blre.2009.04.002_bib102","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2141.2006.06355.x","article-title":"BCSH guidelines on the management of massive blood loss","volume":"135","author":"Stainsby","year":"2006","journal-title":"Br J Haematol"},{"issue":"Suppl. 6","key":"10.1016\/j.blre.2009.04.002_bib103","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1007\/BF03022250","article-title":"The effects of colloid solutions on hemostasis","volume":"53","author":"Van der Linden","year":"2006","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.blre.2009.04.002_bib104","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.TA.0000053245.08642.1F","article-title":"Minimizing dilutional coagulopathy in exanguinating hemorrhage: a computer simulation","volume":"54","author":"Hirshberg","year":"2003","journal-title":"J Trauma"},{"issue":"Suppl. 6","key":"10.1016\/j.blre.2009.04.002_bib105","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1097\/01.ta.0000199549.80731.e6","article-title":"Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol","volume":"60","author":"Malone","year":"2006","journal-title":"J Trauma"},{"key":"10.1016\/j.blre.2009.04.002_bib106","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/TA.0b013e3181271ba3","article-title":"The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital","volume":"63","author":"Borgman","year":"2007","journal-title":"J Trauma"},{"key":"10.1016\/j.blre.2009.04.002_bib107","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1537-2995.2007.01160.x","article-title":"Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice","volume":"47","author":"Johansson","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2009.04.002_bib108","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/bja\/aen270","article-title":"Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations","volume":"101","author":"Fenger-Eriksen","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.blre.2009.04.002_bib109","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.TA.0000066184.20808.A5","article-title":"The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients","volume":"55","author":"Meng","year":"2003","journal-title":"J Trauma"},{"key":"10.1016\/j.blre.2009.04.002_bib110","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1538-7836.2004.01015.x","article-title":"Recombinant human factor VIIa, (rFVIIa) can activate FX on activated platelets","volume":"2","author":"Gabriel","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2009.04.002_bib111","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1080\/00016340600855839","article-title":"Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use","volume":"85","author":"Sobieszczyk","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.blre.2009.04.002_bib112","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1471-0528.2006.01156.x","article-title":"The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage","volume":"114","author":"Franchini","year":"2007","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.blre.2009.04.002_bib113","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijoa.2006.07.005","article-title":"Use of recombinant activated factor VII in massive obstetric haemorrhage","volume":"16","author":"Haynes","year":"2007","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.blre.2009.04.002_bib114","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/01.mbc.0000233370.49099.c0","article-title":"Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience","volume":"17","author":"Payne","year":"2006","journal-title":"Blood Coagul Fibrin"},{"key":"10.1016\/j.blre.2009.04.002_bib115","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bpobgyn.2008.08.010","article-title":"Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage","volume":"22","author":"Searle","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X09000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X09000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T05:48:50Z","timestamp":1633412930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X09000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0268960X09000289"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2009.04.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1163415.625136","asserted-by":"object"}]},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}